Previous studies have also indicated that PRLR antagonists induce human breast cancer cell death in vitro and abrogate tumorigenesis in vivo, while PRLR-knockout in mice prevents mammary tumorigenesis 16,18,40,41, which demonstrates that PRL is essential for the proliferation and survival of these cells. This evidence concerns the gene PRLR and breast cancer.